Protein phosphatase 1 activation and alternative splicing of Bcl-X and Mcl-1 by EGCG + ibuprofen

Related Experiment Video

Updated: Jul 6, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

Myoung H Kim1

  • 1Department of Molecular Biology and Immunology, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA. mkim@hsc.unt.edu

Journal of Cellular Biochemistry
|March 19, 2008
PubMed

Insights

Epigallocatechin-3-gallate (EGCG) and ibuprofen synergistically suppress prostate cancer cell growth. This combination upregulates protein phosphatase 1 (PP1) activity, inducing alternative splicing of Bcl-X and Mcl-1 in a cell-specific manner.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Prostate cancer cell proliferation is a significant therapeutic challenge.
  • Epigallocatechin-3-gallate (EGCG) and ibuprofen show synergistic effects in suppressing prostate cancer cell lines (PC-3 and LNCaP).
  • The underlying molecular mechanisms of this synergism require elucidation.

Purpose of the Study:

  • To investigate the molecular mechanisms behind the synergistic anti-cancer effects of EGCG and ibuprofen.
  • To determine the role of splice variants and protein phosphatase activity in the observed synergism.

Main Methods:

  • Treatment of PC-3 and LNCaP prostate cancer cell lines with EGCG and ibuprofen.
  • Analysis of mRNA levels of Bcl-X and Mcl-1 splice variants (Bcl-X(L), Bcl-X(s), Mcl-1(L), Mcl-1(s)).
  • Assay of protein phosphatase 1 (PP1) activity and assessment of inhibitor effects (calyculin A, tautomycin, okadaic acid).

Main Results:

  • EGCG + ibuprofen treatment altered Bcl-X and Mcl-1 splice variants in PC-3 cells, decreasing anti-apoptotic forms and increasing pro-apoptotic forms.
  • This alternative splicing was linked to increased PP1 activity, as confirmed by inhibitor studies.
  • In LNCaP cells, EGCG + ibuprofen increased PP1 activity but did not alter Bcl-X and Mcl-1 splice variants.
  • Synergistic inhibition of cell proliferation was observed in both cell lines.

Conclusions:

  • EGCG and ibuprofen synergistically upregulate PP1 activity.
  • PP1 activation induces cell-type-specific alternative splicing of Bcl-X and Mcl-1, contributing to anti-cancer effects.
  • PP1 activation is a key mechanism underlying the synergistic efficacy of EGCG and ibuprofen in prostate cancer therapy.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...